OraSure Technologies to Participate at the 2008 UBS Global Life Sciences Conference
18 Settembre 2008 - 3:40PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that
Douglas A. Michels, President and Chief Executive Officer, will
speak to the investment community at the 2008 UBS Global Life
Sciences Conference in New York City at approximately 2:30pm
Eastern Time, (11:30am Pacific Time) on Tuesday, September 23,
2008. The conference will be simultaneously webcast over the
Internet. Interested investors can access the live audio webcast of
the discussion by going to OraSure Technologies� web site,
www.orasure.com, and clicking on the Investor Information link. A
replay of the audio webcast will be available until, September 30,
2008, on OraSure Technologies� web site. About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid
specimen collection devices using proprietary oral fluid
technologies, diagnostic products including immunoassays and other
in vitro diagnostic tests, and other medical devices. These
products are sold in the United States as well as internationally
to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, distributors, government agencies, physicians�
offices, and commercial and industrial entities. OraSure
Technologies is the leading supplier of oral-fluid collection
devices and assays to the life insurance industry and public health
markets for the detection of antibodies to HIV. In addition, the
Company supplies oral-fluid testing solutions for drugs of abuse
testing. For more information on the Company, please go to
www.orasure.com.
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Ott 2023 a Ott 2024